
Guardant Health GH
€ 72.07
-1.54%
Geschäftsbericht 2025
hinzugefügt 19.02.2026
Land |
|
IPO-Jahr |
2018 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBALSPB |
Anteile |
125 M |
Marktkapitalisierung |
$ 10.5 B |
EBITDA (LTM) |
$ -395 M |
P/E (LTM) |
-25.81 |
P/S (LTM) |
13.23 |
EPS (LTM) |
-3.29 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Medpace Holdings
MEDP
|
$ 460.74 | 0.83 % | $ 13.3 B | Nasdaq Global Select Market,SPB | ||
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Bioventus
BVS
|
$ 9.15 | 1.67 % | $ 610 M | Nasdaq Global Select Market | ||
|
Biodesix
BDSX
|
$ 15.54 | 5.79 % | $ 2.02 B | Nasdaq Global Market | ||
|
Myriad Genetics
MYGN
|
$ 4.61 | -1.07 % | $ 427 M | Nasdaq Global Select Market,SPB | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
National Research Corporation
NRC
|
$ 17.44 | -0.4 % | $ 390 M | Nasdaq Global Select Market | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Co-Diagnostics
CODX
|
$ 4.4 | 101.83 % | $ 129 M | Nasdaq Capital Market | ||
|
Pacific Biosciences of California
PACB
|
$ 1.39 | - | $ 417 M | Nasdaq Global Select Market,SPB | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Charles River Laboratories International
CRL
|
$ 159.19 | 0.75 % | $ 7.89 B | NYSE,SPB | ||
|
IQVIA Holdings
IQV
|
$ 166.09 | -0.52 % | $ 28.6 B | NYSE,SPB | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Personalis
PSNL
|
$ 7.78 | 2.23 % | $ 461 M | Nasdaq Global Select Market | ||
|
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | ||
|
BioNano Genomics
BNGO
|
$ 1.18 | -19.18 % | $ 6.43 M | Nasdaq Capital Market,SPB | ||
|
Mettler-Toledo International
MTD
|
$ 1 264.46 | 1.94 % | $ 26.1 B | NYSE,SPB | ||
|
Interpace Biosciences
IDXG
|
$ 1.71 | 0.73 % | $ 7.5 M | Nasdaq Global Select Market | ||
|
Illumina
ILMN
|
$ 125.98 | 1.77 % | $ 20 B | Nasdaq Global Select Market,SPB | ||
|
RadNet
RDNT
|
$ 59.87 | -3.03 % | $ 4.5 B | Nasdaq Global Select Market | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Precipio
PRPO
|
$ 26.6 | -1.23 % | $ 34.5 M | Nasdaq Global Select Market | ||
|
Senseonics Holdings
SENS
|
$ 6.66 | 0.6 % | $ 278 M | NYSE American | ||
|
Sotera Health Company
SHC
|
$ 13.84 | -0.32 % | $ 3.93 B | Nasdaq Global Select Market | ||
|
Celcuity
CELC
|
$ 102.01 | -4.44 % | $ 4.02 B | Nasdaq Global Select Market | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 266.12 | 0.64 % | $ 22.1 B | NYSE,SPB | ||
|
Soleno Therapeutics
SLNO
|
$ 31.34 | -1.2 % | $ 1.59 B | Nasdaq Capital Market | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
ENDRA Life Sciences
NDRA
|
$ 3.46 | -0.57 % | $ 1.86 M | Nasdaq Global Select Market | ||
|
NeoGenomics
NEO
|
$ 7.86 | -2.96 % | $ 1.01 B | Nasdaq Global Select Market,SPB | ||
|
Neuronetics
STIM
|
$ 1.46 | -9.06 % | $ 96.3 M | Nasdaq Global Select Market | ||
|
Natera
NTRA
|
$ 194.52 | -2.78 % | $ 19.1 B | Nasdaq Global Select Market,SPB | ||
|
CareDx, Inc
CDNA
|
$ 17.84 | 1.59 % | $ 951 M | Nasdaq Global Market,SPB | ||
|
OPKO Health
OPK
|
$ 1.13 | -1.74 % | $ 784 M | Nasdaq Global Select Market | ||
|
Castle Biosciences
CSTL
|
$ 25.35 | -1.55 % | $ 704 M | Nasdaq Global Market,SPB | ||
|
DarioHealth Corp.
DRIO
|
$ 7.76 | 3.47 % | $ 30.9 M | Nasdaq Capital Market | ||
|
DexCom
DXCM
|
$ 66.6 | 1.0 % | $ 26 B | Nasdaq Global Select Market,SPB | ||
|
Exact Sciences Corporation
EXAS
|
$ 104.91 | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
Twist Bioscience Corporation
TWST
|
$ 47.49 | 6.72 % | $ 2.84 B | Nasdaq Global Select Market,SPB |